Home Applications 210361 Application 210361
Type NDA
Sponsor DERMIRA INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 QBREXZA GLYCOPYRRONIUM TOSYLATE CLOTH;TOPICAL EQ 2.4% BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N210361-001 QBREXZA GLYCOPYRRONIUM TOSYLATE EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N210361-001 10052267 2028-10-17 U-2398 Drug product 2018-09-20 N210361-001 8618160 2029-12-10 U-2398 Drug product 2018-09-20 N210361-001 9744105 2030-07-18 U-2398 Drug product 2018-09-20 N210361-001 10004717 2033-02-28 U-2398 Drug product 2018-09-20 N210361-001 10543192 2033-02-28 Drug product 2020-02-27 N210361-001 10548875 2033-02-28 U-2398 Drug substance, Drug product 2020-03-03 N210361-001 8859610 2033-02-28 U-2398 Drug product 2018-09-20 N210361-001 9259414 2033-02-28 U-2398 2018-09-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N210361-001 QBREXZA EQ 2.4% BASE CLOTH / TOPICAL RLD, RS 2018-06-28 cb3db0bc1861…
Observed Orange Book patent history# Patent history page 1 of 9 · 326 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N210361-001 10052267 2028-10-17 U-2398 Drug product 2018-09-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210361-001 8618160 2029-12-10 U-2398 Drug product 2018-09-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210361-001 9744105 2030-07-18 U-2398 Drug product 2018-09-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210361-001 10004717 2033-02-28 U-2398 Drug product 2018-09-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210361-001 10543192 2033-02-28 Drug product 2020-02-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210361-001 10548875 2033-02-28 U-2398 Drug substance, Drug product 2020-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210361-001 8859610 2033-02-28 U-2398 Drug product 2018-09-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210361-001 9259414 2033-02-28 U-2398 2018-09-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210361-001 10052267 2028-10-17 U-2398 Drug product 2018-09-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210361-001 8618160 2029-12-10 U-2398 Drug product 2018-09-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210361-001 9744105 2030-07-18 U-2398 Drug product 2018-09-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210361-001 10004717 2033-02-28 U-2398 Drug product 2018-09-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210361-001 10543192 2033-02-28 Drug product 2020-02-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210361-001 10548875 2033-02-28 U-2398 Drug substance, Drug product 2020-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210361-001 8859610 2033-02-28 U-2398 Drug product 2018-09-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210361-001 9259414 2033-02-28 U-2398 2018-09-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N210361-001 10052267 2028-10-17 U-2398 Drug product 2018-09-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210361-001 8618160 2029-12-10 U-2398 Drug product 2018-09-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210361-001 9744105 2030-07-18 U-2398 Drug product 2018-09-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210361-001 10004717 2033-02-28 U-2398 Drug product 2018-09-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210361-001 10543192 2033-02-28 Drug product 2020-02-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210361-001 10548875 2033-02-28 U-2398 Drug substance, Drug product 2020-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210361-001 8859610 2033-02-28 U-2398 Drug product 2018-09-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210361-001 9259414 2033-02-28 U-2398 2018-09-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210361-001 10052267 2028-10-17 U-2398 Drug product 2018-09-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210361-001 8618160 2029-12-10 U-2398 Drug product 2018-09-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210361-001 9744105 2030-07-18 U-2398 Drug product 2018-09-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210361-001 10004717 2033-02-28 U-2398 Drug product 2018-09-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210361-001 10543192 2033-02-28 Drug product 2020-02-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210361-001 10548875 2033-02-28 U-2398 Drug substance, Drug product 2020-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210361-001 8859610 2033-02-28 U-2398 Drug product 2018-09-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210361-001 9259414 2033-02-28 U-2398 2018-09-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210361-001 10052267 2028-10-17 U-2398 Drug product 2018-09-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210361-001 8618160 2029-12-10 U-2398 Drug product 2018-09-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210361-001 9744105 2030-07-18 U-2398 Drug product 2018-09-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210361-001 10004717 2033-02-28 U-2398 Drug product 2018-09-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210361-001 10543192 2033-02-28 Drug product 2020-02-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210361-001 10548875 2033-02-28 U-2398 Drug substance, Drug product 2020-03-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210361-001 8859610 2033-02-28 U-2398 Drug product 2018-09-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210361-001 9259414 2033-02-28 U-2398 2018-09-20 b8a1b40f171c…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2021-12-28 21:50 UTC 2021-12 N210361-001 NP 2021-06-28 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N210361-001 NP 2021-06-28 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N210361-001 NP 2021-06-28 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N210361-001 NP 2021-06-28 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N210361-001 NP 2021-06-28 c0c555d07b60…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 6 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 69489-411 Qbrexza glycopyrronium Journey Medical Corporation NDA Current 69489-411 Qbrexza glycopyrronium Journey Medical Corporation NDA Current 69489-411 Qbrexza glycopyrronium Journey Medical Corporation NDA Current 70428-011 Qbrexza glycopyrronium Dermira, Inc. NDA Current 70428-011 Qbrexza glycopyrronium Dermira, Inc. NDA Current 70428-011 Qbrexza glycopyrronium Journey Medical Corporation NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 72525 SUPPL 2022-11-01 72504 SUPPL 2022-10-31 70694 SUPPL 2022-04-05 70680 SUPPL 2022-04-04 56528 ORIG 2018-11-20 54958 ORIG 2018-07-24 54748 ORIG 2018-07-05 63064 ORIG 1900-01-01